Fanetizole mesylate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 525038

CAS#: 79069-95-7

Description: Fanetizole mesylate is an immunoregulator agent.


Price and Availability

Size
Price

Size
Price

Size
Price

Fanetizole mesylate is not in stock, but may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 525038
Name: Fanetizole mesylate
CAS#: 79069-95-7
Chemical Formula: C18H20N2O3S2
Exact Mass:
Molecular Weight: 376.49
Elemental Analysis: C, 57.42; H, 5.35; N, 7.44; O, 12.75; S, 17.03


Synonym: Fanetizole mesylate; UNII-D3OG7B0G4M; Fanetizole mesylate (USAN); Fanetizole mesylate [USAN]; C1MHW3X; CP 48810; CP-48,810; fanetizole.

IUPAC/Chemical Name: 2-(Phenethylamino)-4-phenylthiazole monomethanesulfonate

InChi Key: FHXKFCNUYSGNFV-UHFFFAOYSA-N

InChi Code: InChI=1S/C17H16N2S.CH4O3S/c1-3-7-14(8-4-1)11-12-18-17-19-16(13-20-17)15-9-5-2-6-10-15;1-5(2,3)4/h1-10,13H,11-12H2,(H,18,19);1H3,(H,2,3,4)

SMILES Code: CS(=O)(=O)O.c1ccc(cc1)CCNc2nc(cs2)c3ccccc3


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Styrt B, Rocklin RE, Klempner MS. Inhibition of neutrophil superoxide production by fanetizole. Inflammation. 1985 Sep;9(3):233-44. PubMed PMID: 2995253.

2: Antonacci AC. How do immunomodulators affect host defense in the burn patient? J Trauma. 1984 Sep;24(9 Suppl):S101-18. PubMed PMID: 6384529.

3: Rocklin RE, Hemady Z, Matloff S, Kiselis I, Lima M. Correction of an in vitro immunoregulatory defect in atopic subjects by the immunostimulating drug fanetizole mesylate (CP-48,810). Int J Immunopharmacol. 1984;6(1):1-8. PubMed PMID: 6233230.